Hanmi Pharmaceutical will likely dominate the erectile dysfunction treatment market, divided into sildenafil (original: Viagra) and tadalafil (original: Cialis).The company has led the sildenafil market with Palpal, a Viagra generic, and is almost claiming the largest market share for tadalafil, mar
HK inno.N said that it had signed a business agreement with Ilias Biologics to research exosome-based new drug candidates jointly.Under the accord, the two companies plan to work closely together to discover new drug candidates using exosomes, attracting attention as a next-generation drug delivery
Hanmi Pharmaceutical said it has incorporated Spectrum, its U.S. partner, into an affiliate company ahead of commercializing its new drugs globally.Hanmi invested about 24 billion won ($19.1 million) in Spectrum earlier this year to expand its stake in the latter to 8.6 percent. Although the stake d
Daewoong Pharmaceutical’s sales of prescription drugs have expanded significantly this year.In April, Daewoong’s revenue from prescription drugs exceeded 70 billion won ($55.69 million).Accumulated sales in the first four months of 2022 recorded 267.5 billion won, up 14.3 percent from the same perio
GC Wellbeing said Friday that a joint study with Chungbuk National University College of Medicine found that human placental extract Laennec has an antiviral effect against the Covid-19’s Delta and Omicron variants.The company infected Vero cells, African green monkey kidney cells, with the Delta an
“When the EMA reviewed our biosimilar HD201, it neither considered the product drift of the original drug Herceptin nor applied consistent criteria for analytic equivalence comparison. As a scientist, I could not accept such an unscientific approach, which is why we applied for re-examination. There
Janssen Korea said that the Ministry of Health and Welfare would begin to reimburse Tremfya, its psoriatic arthritis treatment, from this month.According to the current standard, the health authorities will provide reimbursement to patients with active and progressive cases where the response to one
Novo Nordisk Korea has recently launched two new type 2 diabetes drugs – Rybelsus and Ozempic – raising expectations among local doctors that the drug will become a game-changer for Korean patients."One of the most important aspects of treating type 2 diabetes is to reduce cardiovascular complicatio
AngioLab announced the results of the phase 2 McEye study of ALS-L1023, an investigational drug to treat wet age-related macular degeneration (AMD).The company explored the optimal dose of ALS-L1023 combined with ranibizumab (brand name: Lucentis) and evaluated the safety and efficacy in 126 patient
Hanmi Pharmaceutical said the company would start marketing its blockbuster hypertension drug Amosartan under the brand name Meiyaping in China in September. It marked the first homegrown blood pressure combination therapy to enter the Chinese market.The launch follows Beijing Hanmi Pharmaceutical,
GC Pharma said it obtained marketing approval for Rozetelpine, a four-drug combination treatment for hypertension/hyperlipidemia.Rozetelpine combines hypertension medicines telmisartan and amlodipine with hyperlipidemia drugs rosuvastatin and ezetimibe.GC Pharma confirmed Rozetelpine’s efficacy in a
Chong Kun Dang said it would exclusively market Baxter Korea’s Caelyx, a recurrent ovarian cancer treatment, in Korea. Under the contract, Chong Kun Dang will distribute, sell, and market Caelyx to Korean hospitals and clinics from July.“We will strategically conduct distribution, sales, and marketi
Genencell said that it has signed an exclusive distributorship agreement with Ordi Pharma FZ-LLC, a UAE-based pharmaceutical company, for the exclusive distribution rights of ES16001, an oral Covid-19 treatment, in Middle East countries and Turkey.Ordi Pharma is a subsidiary of DEM Pharmaceuticals,
Janssen has launched Rybrevant (ingredient: amivantamab), a treatment for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation, raising expectations for a new treatment option.Rybrevant, the first fully human-derived bispecific antibody approved
Daewoong Pharmaceutical said it has submitted a new drug application (NDA) for Fexuprazan, its gastroesophageal reflux treatment, to four Latin American countries -- Mexico, Chile, Ecuador, and Peru.Fexuprazan is undergoing a product approval process in eight countries, the company said.Daewoong sai
Korean pharmaceutical companies, including Hanmi Pharmaceutical, LG Chem, and Yuhan Corp., are accelerating efforts to develop a new obesity drug with a new mechanism of action, a report said.On Monday, Korea Biotechnology Industry Organization (Korea BIO) released a report titled “Global Trends of
SK Bioscience said that it exported the first batch of SKY Varicella, a chickenpox vaccine, to the Pan America Health Organization (PAHO), an international health organ under the United Nations.Along with UNICEF, PAHO is one of the world's largest vaccine suppliers and is responsible for the large-s
Boryung Corp. said it recorded the largest quarterly earnings in the first quarter of 2022 in its history, continuing a solid growth after 2021.The company’s sales and operating profit posted 170.6 billion won ($134.4 million), and 18.7 billion won in the first quarter, up 26 percent and 36 percent
Astellas Pharma, a multinational pharmaceutical company based in Japan, has released a report detailing the disadvantages of living with bladder cancer and its psychological impact.Bladder cancer is the fifth most common cancer globally, with 151,000 new cases diagnosed in Europe alone every year. H
The drug regulator ordered Samsung Pharm to suspend manufacturing of hypertension drug Amonepin Tab. (ingredient: amlodipine maleate), saying the drugmaker violated the Good Manufacturing Practices (GMP).On Friday, the Ministry of Food and Drug Safety said Samsung Pharm received a four-month suspens